Replies to post #311640 on Bioelectronics Corp (BIEL)

[JNdouble1]

Again! not a change.

The excuse from both the CEO and Investor Relations is that there are changes to the OTC reporting guidelines that have caused a delay.

The challenge is figure out what those changes are. I provided good starter sources.

How about this for example; they lost their address book, and they can't remember who the insiders are. Have some fun, be creative!

[ddls]

Nah! they've had long enough, like months.

Maybe their lawyer is as incompetent as Kelly.

What a team this matches up to be.

Declining Sales Cheers!~~

[GetSeriousOK]

The lawyer does not have to sign off on the financials or the Disclosure statement.

The truth is: when a company files an extension, they often cite a BS reason, and OTC markets (or in the case of a NT-10K, the SEC) doesn't bother to check. In other words -- the excuse "changes to OTC reporting" is BS but nobody cares.

Happens all the time.

Now let's all practice saying "Ummmmm China Was In Lockdown."